© Copyright Nostre Net
EHR-EMR Market Insights
The growth of healthcare IT and its immense potential in consolidating data as well its ability to drastically increase efficiency has impacted the global & US EHR-EMR market to a great extent. Market Research Future has released its report on the global US EHR-EMR market which includes various intelligent insights as well a collection of highly relevant facts and figures with regards to the future of the market for the review period from 2018 to 2027. According to findings of the analysis carried out by MRFR, the global & US EHR-EMR market is expected to register a CAGR of 5.82% during the review period which is likely to result in a market value of USD 42,427.27 Mn by the end of 2027.
EHRs & EMRs help avoid medical errors which are often encountered during the diagnosis and treatment process due to the lack of awareness on the part of medical professionals regarding medical history and therapeutic guidelines specific to the patient. Moreover, reportedly, clinical decisions made using the assistance of EHRs have increased the efficiency of care. These clinical benefits are significant in their positive impact on the global & US EHR-EMR market. Increasing government support of EHRs have also been a strong driving factor for the adoption of EHRs & EMRs as well as the subsequent growth of the global market. Prime examples include the NHS which has implemented the Integrated Digital Care Fund to support the shift from paper-based health records to integrated digital care records. These types of supportive, and encouraging government initiatives are expected to compel market growth over the review period.
Market Segmentation
Components of EHR & EMR have been segmented into software, services & consulting, and hardware. The software segment has captured a 59.1% share of the market and is also projected to expand at the highest growth rate during the assessment period.
Applications of EHR & EMR are largely divided between the specialty based segment and general based segment. The specialty based segment is further sub-segmented to include neurology, oncology, radiology, cardiology, and others. The specialty based segment has not only captured the largest share of the global & US EHR-EMR market but is also anticipated to expand at the fastest pace at a CAGR of 6.02% during the review period. The rapid growth of the specialty-based segment is due to the increasing incidences of cardiovascular diseases as well as a high prevalence of chronic diseases.
Mode of delivery of EHR and EMR has been segmented into cloud-based, and on-premise model. The on-premise segment is the most significant segment in the global market. However, the rapid growth of the cloud-based segment is expected to bring both segments nearly at par by the end of 2027.
End-users of EHRs and EMRs have been segmented into ambulatory care, diagnostic centers, hospitals & clinics, and others. Hospitals & clinics are the dominant segments in the global & US EHR-EMR market due to the increasing adoption of healthcare IT in this segment. However, the ambulatory segment is growing at the most rapid pace due to the demand for instant data retrieval in emergency healthcare situations.
Regional Analysis
MRFR's coverage of the global market scenario covers key regions such as the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas have the dominant share of the global & US EHR-EMR market. The North American segment of the market which includes the US has a strong presence of several market leaders as well as a thriving healthcare sector. The well-developed healthcare sector in the region has an affinity toward the adoption of advanced IT technology. Growing investments in healthcare and increasing demand for advanced healthcare. IT is likely to lead the market to grow over the review period.
Meanwhile, the Asia Pacific market is on track to grow at the most significant CAGR of 6.77%. Japan is the largest country-level market. Other important country level markets include India, China, and Austrailia. The rapid digitization of the regions healthcare segment, combined with the healthcare reforms taking place are expected to drive the APAC's growth over the review period. Increasing awareness regarding electronic health records, a rising geriatric population as well as the presence of a significant and growing patient pool is expected to influence the EHR-EMR market positively.
Key Players
Market Research Future has tracked the competition in the global & US EHR-EMR market and analyzed the various growth strategies used by leading market players. Market players of prominence included in the report are Allscripts Healthcare Solutions, Athenahealth Inc., Agastha Inc, Cerner Corporation, Epic Systems, eClinicalWorks, Advanced MD Inc, Advanced Data Systems Corporation, GE Healthcare, Medical Information Technology Inc., Koninklijke Philips N.V., and Meddbase (Medical Management Systems Ltd).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Global Surgical Robots Market is growing with the rapid pace mainly due to the burgeoning Healthcare Industry. According to a recent study report published by the Market Research Future, The global Surgical Robots market size is projected to reach approximately $21.41 billion by 2030, at a CAGR of 19.87% from 2022 to 2030.
Advancements in technology have empowered surgeons to remotely operate robots and perform surgery. Surgeons can perform a surgical procedure in emergency situations through telesurgery, with the aid of an imaging device. There are many advantages of robotic surgery over traditional open surgery like more accuracy, less pain, small insertions and many more. Increasing automation in healthcare sector and increasing demand for the minimally-invasive surgeries and more advances robotics has led to growth of this market across the globe. Beside this increasing incident of cancer, different neurological disorders and many more diseases has provided fuel for the growth of the market. Additionally, advancements in technology over the fast few years have been directed towards reducing costs of products. This has led to increasing applications of these robots for various tasks.
Today, Robots are used not just for prostate surgery, but for hysterectomies, the removal of fibroids, joint replacements, open-heart surgery and kidney surgeries. They can be used along with MRIs to provide organ biopsies. The invention of robots has not only ease surgeon’s work but also play a very important role in the automation technology.
Surgical Robots Global Market – Competitive Analysis
Characterized by the presence of well-established players; Surgical Robots market appears to be highly competitive. Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position. Vendors are focusing on improving their market performance and are expanding by acquiring promising companies in the fast-growing markets. Marketers employ a continuous improvement strategy to analyze and update the software, implementing improvements and launching new technologies to meet the changing needs of consumer. These manufactures develop a well-established infrastructure that allows seamless implementation of advanced technologies. They strive to develop unravel design and adept technology Heavy investments are transpired in R&D sector from the major players which is in turn helping the market to grow.
Surgical Robots Global Market – Segments
The Surgical Robots Market can be segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;
Segmentation By Control Mechanism : Comprises Direct Telemanipulator and Computer Control.
Segmentation By Robotic Surgery Approach : Comprises Supervisor-Controlled Robotic Surgical System, Shared Control Robotic Surgical Systems, Telesurgery Systems, Robotic Radiosurgery Systems.
Segmentation By Application : Comprises General Surgery, Cardiac Surgery, Gynecologic Surgery, Colorectal Surgery, Urologic Surgery, Head and Neck Surgery and other.
Segmentation By Regions : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.
Surgical Robots Global Market – Regional Analysis
On regional basis, America has the largest market for surgical robots. Availability of finance, well developed healthcare sector with continuous increasing prevalence of number of diseases are the major driving factor for America surgical robots market. North America is the major contributor for the Americas surgical robots market. In 2016, North America surgical robots market was USD 1,655.8 million. Europe has second leading market which is followed by Asia Pacific region. Increasing prevalence of diseases like cancer and many neurological disorder in Europe has help to grow this market. Asia Pacific region is showing slow growth for surgical robot market. Asia Pacific surgical robots market is expected to grow at a CAGR of 23.36 % forecast period from 2017-2023
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Cell Isolation Market is expected to reach USD 17,286 Million by 2030 at 17.8% CAGR during the forecast period 2022-2030. The escalated level of emphasis on biotechnological research is encouraging the growth of cell isolation market. Reports that appraise the healthcare industry have been made accessible by Market Research Future, which produces reports on several industry verticals that examine the market growth and prospects.
The cost-effective benefits harnessed from the use of cell isolation techniques is expected to be a major factor motivating the development of the market in the coming years. The use of cell isolation for applications such as microarray hybridization, biomarker identification, and genetic analysis is expected to bolster the market progress in the approaching period.
The central players shaping the cell isolation market comprise of Becton, Dickinson & Company, STEMCELL Technologies, GE Healthcare, Beckman Coulter, Merck KGaA., TERUMO Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Miltenyi Biotec, F.Hoffman-La Roche AG, and others
Cell Isolation Market Segmental Analysis
The segmental analysis of the cell isolation market is segmented on the basis of cell type, product, end-user, technique, application, and region. Based on the product, the cell isolation market is segmented into instruments and consumables. The segmentation of the cell isolation market report based on cell type comprises of animal cells and human cells. Based on the cell isolation techniques, the cell isolation market is segmented into surface marker-based cell isolation, centrifugation-based cell isolation, and filtration-based cell isolation. Based on application, the market for cell isolation is segmented into cancer research, biomolecule isolation, stem cell research, in-vitro diagnostics, tissue regeneration, and therapeutics. On the basis of end-user, the cell isolation market is segmented into biotechnology & biopharmaceutical companies, research laboratories & institutes, cell banks, and hospitals & diagnostic laboratories. On the basis of regions, the cell isolation market is segmented into the Americas, Europe, Asia Pacific, Africa, and the Middle East.
Cell Isolation Market Regional Analysis
The regional examination of the cell isolation market comprises of regions such as the Americas, Europe, Asia Pacific, Africa, and the Middle East. The Americas region is in charge of the principal segment of the overall market presently. The growing incidence of chronic diseases, mounting expenses in R&D activities directed by healthcare organizations and government bodies along with the growing demand for proper treatment options, are motivating the regional market. Additionally, the region is also technologically progressive, and emerging countries in the region possess considerably established healthcare sectors which are at the forefront of pioneering research and technology. In the meantime, the Asia Pacific is likely to improve at a vigorous CAGR of 17.7% throughout the forecast period. The incidence of an enormous population with a substantial patient pool as compared to other regions and the continuing initiatives presented by the government to restructure the healthcare sector is projected to motivate the market. Nations such as Singapore, Australia, and Malaysia, among others, are the greatest lucrative markets in the region and include large patient pools, increased amount of geriatric population and quickly improving healthcare facilities. The market is controlled by the absence of appropriate capital, among other factors. Though, a supportive regulatory framework concerning biotechnology research is anticipated to lift market growth.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global Drugs Of Abuse Testing Market is expected to grow at a CAGR of 5.33% over the forecast period from 2019 to 2025, according to a new research report from Market Research Future (MRFR). A detailed profile of the global drug of abuse testing market is presented in the report, including an analysis of the key players operating in the market, the market’s leading drivers and restraints, and the leading segments holding a dominant share in the market. The past growth trajectory of the global drug of abuse testing market is also examined in detail in the report to enlighten readers as to the likeliest growth trajectory of the market in the forecast period. The global drugs of abuse testing market is expected to rise to a value of more than USD 5 billion by the end of the forecast period in 2025, according to the report.
The growing use of illicit drugs all over the world and the growing awareness about drug of abuse testing are the major drivers for the global drugs of abuse testing market. Due to the growing number of youths becoming addicted to illegal substances, many governments around the world have come up with strong anti-drugs policies. Strict enforcement of drug monitoring policies is being practiced in most countries around the world. This has led to a growing demand for drugs of abuse testing equipment. This is likely to remain the major driver for the global drug of abuse testing market over the forecast period due to the increasing government efforts to fight growing drug usage.
Technological refinement of small, portable drug of abuse testing devices is likely to be a major target for players in the global drug of abuse testing market over the forecast period. Parents are becoming increasingly concerned about illegal drug use by their wards, which has led to a growing demand for home-based testing for drugs. Drug of abuse testing equipment indicates whether drugs have been consumed within a specific timeframe, but they are not very good at revealing addiction patterns. This is likely to be a key restraint against the global drugs of abuse testing market over the forecast period.
Competitive Analysis:
Leading players in the global drug of abuse testing market include Quest Diagnostics, Thermo Fisher Scientific Inc., LabCorp, F. Hoffman-La Roche Ltd., Abbott Laboratories, Sonic Healthcare, Randox Laboratories, and Bio-Rad Laboratories Inc.
Segmentation:
The global drug of abuse testing market is segmented on the basis of test type and sample type.
By test type, the global drug of abuse testing market is segmented into drugs of abuse testing laboratory and onsite screening tests. Onsite screening tests comprise the dominant segment due to the higher convenience and cost-effectiveness of onsite screening. The onsite screening tests segment held a dominant 71.62% share in the market in 2018.
On the basis of sample type, the drug of abuse testing market is segmented into urine, hair, saliva and others. Urine holds a majority share in the global drug of abuse testing market, as urine contains metabolites from several types of drugs. Saliva is the second most popular sample type in the drug of abuse testing market.
Regional Analysis:
The global drug of abuse testing market is segmented by region into North America, Europe, Asia Pacific, and rest of the world.
North America is the dominant revenue generator in the global drug of abuse testing market. The U.S. is the top consumer of drug of abuse testing devices and is likely to retain the position over the forecast period due to the strict enforcement of anti-drug legislation in the country. Awareness among parents about drug use among teenagers is also increasing, which is likely to be a key driver for the drug of abuse testing market in the U.S.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Actinic keratosis, simply put, is a scaly, rough patch on the skin which results from years of sun exposure. It is commonly found on the neck, scalp, forearms, back of the hands, ears, lips, or face. The size varies from a small inch to about a diameter, and when left untreated, such areas of the skin can turn into a serious type of skin cancer. Change in the color of the skin (brown, flesh-colored, or pink), hard wart-like surface, burning sensation and itching, and rough, patchy, scaly skin are some of its common symptoms.
The global actinic keratosis treatment market is predicted to touch USD 6,088.4 million at a 4.20% CAGR over the forecast period (2015-2024), states the new Market Research Future (MRFR) report.
No two cases will appear the same, yet is likely to share similar features such as sandpaper texture, crusty patches, raised patches, and red scales. Though anyone can develop actinic keratosis, but those with fair skin, particularly blonde or red hair, green or blue eyes, or skin that easily burns or freckles have a higher risk of experiencing actinic keratosis.
Various factors are propelling the porokeratosis treatments growth. These factors, according to the new MRFR report, include its increasing prevalence, increasing acceptance of therapeutic procedures that are minimally invasive, growing geriatric population, and the presence of suitable medical coverage. Additional factors pushing market growth include the availability of suitable medical attention and environmental factors such as excessive sun exposure and ozone depletion.
Key Players
Leading players profiled in the actinic keratosis treatment market report include Cipher Pharmaceuticals Inc., Valeant Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Alma Lasers, Stanford Chemicals, 3M, Leo Pharma, BioLineRx, and Biofrontera AG. Various strategies have been adopted by key players to create a foothold in the market such as research and development activities, joint ventures/partnership, mergers and acquisitions, collaborations, expansions, product launches, and development.
Market Segmentation
The MRFR report provides a complete segmental analysis of the actinic keratosis treatment market report on the basis of end user, procedure, and medication.
Based on medication, the actinic keratosis treatment market is segmented into diclofenac gel, ingenol mebutate gel, imiquimod cream, fluorouracil cream, and others.
Based on procedure, the actinic keratosis treatment market is segmented into chemical peels, laser, photodynamic therapy, cryotherapy, and others. Of these, the cryotherapy segment will have the largest share in the market over the forecast period. This is a common treatment used for actinic keratosis.
Based on end user, the actinic keratosis treatment is segmented into ambulatory surgical centers, dermatology clinics, and hospitals and oncology centers. Of these, the hospitals and oncology segment will dominate the market over the forecast period.
Regional Analysis
By region, the actinic keratosis treatment market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. Factors aiding growth in the region include easy availability of advanced treatment methods such as monotherapy and combination therapy and increasing efforts taken on cancer research in the region.
The actinic keratosis treatment market in the APAC region is predicted to have significant growth over the forecast period. Factors aiding growth in the region include growing government support for medical tourism, rising healthcare spending, rising literacy rates, rapidly growing healthcare infrastructure, and rising disposable income. India, Japan, and China are the key contributors in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
It is estimated that the global preimplantation genetic testing market is expected to register a CAGR of 10.2% during the forecast period of 2019 to 2025, with a market value of USD 375.8 million in 2018.
Preimplantation genetic testing is the testing at the pre-implantation stage for detection of genetic defects in embryos or oocytes. Preimplantation genetic testing has occurred more frequently in recent years in North America and Europe, due to the advancement in genetic technology.
The decreasing fertility rates worldwide enhance the acceptance of the preimplantation genetic testing to avoid further complications of chromosomal abnormalities with advancing maternal age. This leads to the growth of the genetic testing for rare diseases during the forecast period. According to the Vital Statistics Rapid Release, the total fertility rate for the US in 2017 was 1,764.5 births per 1,000 women, and in 2016 it was 1,820.5, which is 3% less, this shows the reduction in the rate of fertility.
An increasing number of fertility clinics worldwide, new development technological advancements in the field of genetic analysis and high threat of chromosomal abnormalities with advancing maternal age are the other driving factors for global preimplantation genetic testing market
Key Players
Some of the major players in the global preimplantation genetic testing market are Natera, Inc.CooperSurgical, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., IGENOMIX, Reprogenetics, LLC, Genea Limited, PerkinElmer, Inc., Genesis Genetics Ltd., Quest Diagnostics Incorporated, Thermo FisherScientific, Inc, Bioarrayn Genetics, Laboratory Corporation of America Holdings, California Pacific Medical Center and Reproductive Health Science Ltd
Segmentation
The global preimplantation genetic testing market is segmented based on procedure, type, application, technology, product and service, end user, and region.
The global market for preimplantation genetic testing, by procedure, is segmented into preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS). Hundred different genetic conditions can be tested with Preimplantation Genetic Diagnosis (PGD) which enables the couple to have a baby with no genetic defect thus the segment is expected to hold the largest market share owing to rising awareness population and healthcare experts. Preimplantation Genetic Screening (PGS) segment is also anticipated to grow profitably to increase healthy pregnancy.
By type, embryo testing segment is expected to show favorable growth as the threat of chromosomal abnormalities increases. By product and service, the reagents and consumables segment anticipated to hold the largest market share as there is continuous declination infertility of female due to increasing usage of reagents for the diagnosis. By technology, the next-generation sequencing segment, and comparative genomic hybridization also expected to hold large share as its cost is reduced and its capability to detect mosaicism. The market by end user has been segmented into maternity centers & fertility clinics
hospitals, diagnostic labs and research laboratories & academic institutes. Based on region, the global preimplantation genetic testing market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The global preimplantation genetic testing market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European global preimplantation genetic testing market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The global preimplantation genetic testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The IPF treatment market in the Middle East & Africa has been divided into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.